Australia Vaccine Passes First Trial For Treating Celiac Disease
This article was originally published in PharmAsia News
Executive Summary
Aussie researchers report a Phase I trial of a vaccine to prevent celiac disease has been successful, leading to a decision to proceed through the next stages